MAB21L3 and attention deficit-hyperactivity disorder: Regarding dopamine receptors, these compounds did not show affinity towards either the D2 or the D5 subtypes and only compound 1 displayed low affinity for the D1 and D4 receptors (involved in Parkinson's disease and attention deficit hyperactivity disorder, respectively) (Table 1).